SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-075294
Filing Date
2020-06-19
Accepted
2020-06-19 16:54:31
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 tm2022878-1_s3.htm S-3 570443
2 EXHIBIT 4.4 tm2022878d2_ex4-4.htm EX-4.4 495963
3 EXHIBIT 4.6 tm2022878d2_ex4-6.htm EX-4.6 115622
4 EXHIBIT 4.7 tm2022878d2_ex4-7.htm EX-4.7 115405
5 EXHIBIT 4.8 tm2022878d2_ex4-8.htm EX-4.8 102370
6 EXHIBIT 5.1 tm2022878d2_ex5-1.htm EX-5.1 27320
7 EXHIBIT 23.1 tm2022878d2_ex23-1.htm EX-23.1 2511
8 GRAPHIC lg_milestonepharma-4c.jpg GRAPHIC 505783
9 GRAPHIC tm2022878d2_ex5-1img001.jpg GRAPHIC 8946
10 GRAPHIC tm2022878d2_ex5-1img002.jpg GRAPHIC 1667
  Complete submission text file 0001104659-20-075294.txt   2104125
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-239318 | Film No.: 20976276
SIC: 2834 Pharmaceutical Preparations